Over the last few years Johnson’s Baby Powder, has faced controversy over claims that its talc-based formula contains asbestos that may have led to cancer in thousands of women.

In 2018, Johnson & Johnson was ordered to pay $4.69 billion to 22 women in one case, and investigations by Reuters and The New York Times uncovered internal documents that appeared to indicate that some people at the brand over the years worried about the presence of asbestos.

While strongly denying any wrongdoing, and calling those reports “false and inflammatory,” Johnson & Johnson has announced that it will no longer be selling talc-based baby powder in North America.

The announcement was posted to Johnson & Johnson’s corporate website on Tuesday, May 19. In it, the brand states that, in response to the shifting of prioritized products during the COVID-19 pandemic, it will permanently discontinue approximately 100 SKUs, and their talc-based Johnson’s Baby Powder is one of the items on the list.

The Company plans to wind down the commercialization of talc-based Johnson’s Baby Powder in the U.S. and Canada in the coming months with existing inventory sold through retailers until stocks run out.

Their cornstarch-based Johnson’s Baby Powder will still remain available in North America, but the announcement mentioned that both types of baby powder will continue to be sold in other markets around the world where there is higher demand.